Myriad Genetics | MYGN - Interest Expense On Debt


Myriad Genetics reported $4.4M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 29M 4M Jun/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Bio-Rad Laboratories USD 12.1M 200K Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Danaher USD 135M 28M Sep/2026
Illumina USD 24M 0 Jun/2026
J&J USD 43M 25M Mar/2026
Mettler Toledo International USD 17.25M 239K Jun/2026
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quest Diagnostics USD 61M 8M Sep/2026
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.71M 49K Sep/2026
Revvity USD 22.99M 1.73M Jun/2026
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 417M 63M Sep/2026
Veracyte USD 2K 1000 Dec/2023
Waters USD 55M 13M Jun/2026